Mechanisms of Resistance to Chemotherapy in Gastric Cancer.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Anti-Cancer Agents in Medicinal Chemistry

• Publication date

  2016-02-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/1871520615666150803125121PMID 26234359
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Macrophage-derived reactive oxygen species suppress miR-328 targeting CD44 in cancer cells and promote redox adaptation.

  2014cited by this paper
• Association between Polymorphisms in XRCC1 Gene and Treatment Outcomes of Patients with Advanced Gastric Cancer: A Systematic Review and Meta-Analysis

  2014cited by this paper
• Genistein-Inhibited Cancer Stem Cell-Like Properties and Reduced Chemoresistance of Gastric Cancer

  2014cited by this paper
• miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1

  2014cited by this paper
• Downregulation of histone deacetylase 1 by microRNA‐520h contributes to the chemotherapeutic effect of doxorubicin

  2014cited by this paper
• VEGF‐C mediates RhoGDI2‐induced gastric cancer cell metastasis and cisplatin resistance

  2014cited by this paper
• TXNL1-XRCC1 pathway regulates cisplatin-induced cell death and contributes to resistance in human gastric cancer

  2014cited by this paper
• Expression of GRP78 predicts taxane-based therapeutic resistance and recurrence of human gastric cancer.

  2014cited by this paper
• MicroRNA-185 regulates chemotherapeutic sensitivity in gastric cancer by targeting apoptosis repressor with caspase recruitment domain

  2014cited by this paper
• The Met receptor tyrosine kinase: a key player in oncogenesis and drug resistance.

  2014cited by this paper
• RNAi-mediated silencing of ATP-binding cassette C4 protein inhibits cell growth in MGC80-3 gastric cancer cell lines.

  2014cited by this paper
• Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial.

  2014cited by this paper
• Non-platinum-based chemotherapy for treatment of advanced gastric cancer: 5-fluorouracil, taxanes, and irinotecan.

  2014cited by this paper
• Targeting receptor tyrosine kinases in gastric cancer.

  2014cited by this paper
• Lack of association of the MDR1 C3435T polymorphism with susceptibility to gastric cancer and peptic ulcer: a systemic review and meta-analysis.

  2014cited by this paper
• Tamoxifen reduces P-gp-mediated multidrug resistance via inhibiting the PI3K/Akt signaling pathway in ER-negative human gastric cancer cells.

  2014cited by this paper
• Up‐regulation of survivin by AKT and hypoxia‐inducible factor 1α contributes to cisplatin resistance in gastric cancer

  2014cited by this paper
• Endoscopic treatment for early gastric cancer.

  2014cited by this paper
• MicroRNA-362 induces cell proliferation and apoptosis resistance in gastric cancer by activation of NF-κB signaling

  2014cited by this paper
• miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2.

  2014cited by this paper
• Mitochondrial and postmitochondrial survival signaling in cancer.

  2014cited by this paper
• Treatment of gastric cancer.

  2014cited by this paper
• Adjuvant or neoadjuvant therapy for operable esophagogastric cancer?

  2014cited by this paper
• Regulatory mechanism of ZNF139 in multi-drug resistance of gastric cancer cells

  2014cited by this paper
• Relationship between P53 Status and Response to Chemotherapy in Patients with Gastric Cancer: A Meta-Analysis

  2014cited by this paper
• Polymorphism of TS 3′-UTR predicts survival of Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel

  2013cited by this paper
• The role of reduced intracellular concentrations of active drugs in the lack of response to anticancer chemotherapy

  2013cited by this paper
• Celecoxib antagonizes the cytotoxic effect of cisplatin in human gastric cancer cells by decreasing intracellular cisplatin accumulation.

  2013cited by this paper
• A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker

  2013cited by this paper
• The association between chemosensitivity and Pgp, GST-π and Topo II expression in gastric cancer

  2013cited by this paper
• The MicroRNA-21/PTEN Pathway Regulates the Sensitivity of HER2-Positive Gastric Cancer Cells to Trastuzumab

  2013cited by this paper
• Long-Term Cisplatin Exposure Promotes Methylation of the OCT1 Gene in Human Esophageal Cancer Cells

  2013cited by this paper
• ERCC1 predicts outcome in patients with gastric cancer treated with adjuvant cisplatin-based chemotherapy

  2013cited by this paper
• Antitumor efficacy of a recombinant adenovirus encoding endostatin combined with an E1B55KD-deficient adenovirus in gastric cancer cells

  2013cited by this paper
• Contribution of Abcc4-Mediated Gastric Transport to the Absorption and Efficacy of Dasatinib

  2013cited by this paper
• Involvement of miR-20a in Promoting Gastric Cancer Progression by Targeting Early Growth Response 2 (EGR2)

  2013cited by this paper
• Anti-cancer effects of newly developed chemotherapeutic agent, glycoconjugated palladium (II) complex, against cisplatin-resistant gastric cancer cells

  2013cited by this paper
• A genetic variant in ERCC2 is associated with gastric cancer prognosis in a Chinese population.

  2013cited by this paper
• Survivin promoter-regulated oncolytic adenovirus with Hsp70 gene exerts effective antitumor efficacy in gastric cancer immunotherapy

  2013cited by this paper
• Survivin −31G>C Polymorphism and Gastrointestinal Tract Cancer Risk: A Meta-Analysis

  2013cited by this paper
• MicroRNA-200c Regulates the Sensitivity of Chemotherapy of Gastric Cancer SGC7901/DDP Cells by Directly Targeting RhoE

  2013cited by this paper
• Identification of Transporters Associated with Etoposide Sensitivity of Stomach Cancer Cell Lines and Methotrexate Sensitivity of Breast Cancer Cell Lines by Quantitative Targeted Absolute Proteomics

  2013cited by this paper
• Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients.

  2013cited by this paper
• Relationship between Glutathione S-Transferase P1 (GSTP1), X-Ray Repair Cross Complementing Group 1 (XRCC1) and 5,10-Methylenetetrahydrofolate Reductase (5,10-MTHFR) Gene Polymorphisms and Response to Chemotherapy in Advanced Gastric Cancer

  2013cited by this paper
• Differential expression and prognostic value of ERCC1 and thymidylate synthase in resected gastric adenocarcinoma

  2013cited by this paper
• Co-transduction of ribosomal protein L23 enhances the therapeutic efficacy of adenoviral-mediated p53 gene transfer in human gastric cancer.

  2013cited by this paper
• Role of ABCG2 expression driven by cisplatin in platinum-containing chemotherapy for gastric cancer.

  2013cited by this paper
• Overexpression of AKT decreases the chemosensitivity of gastric cancer cells to cisplatin in vitro and in vivo.

  2013cited by this paper
• MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN.

  2013cited by this paper
• Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence

  2013cited by this paper
• Knockdown of MDR1 increases the sensitivity to adriamycin in drug resistant gastric cancer cells.

  2013cited by this paper
• Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib

  2013cited by this paper
• Genetic polymorphisms of ERCC1‑118, XRCC1‑399 and GSTP1‑105 are associated with the clinical outcome of gastric cancer patients receiving oxaliplatin‑based adjuvant chemotherapy.

  2013cited by this paper
• Decreased expression of microRNA let-7i and its association with chemotherapeutic response in human gastric cancer

  2012cited by this paper
• Overexpression of βIII-tubulin and survivin associated with drug resistance to docetaxel-based chemotherapy in advanced gastric cancer.

  2012cited by this paper
• miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP

  2012cited by this paper
• MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome

  2012cited by this paper
• Impact of Expression of Human Epidermal Growth Factor Receptors EGFR and ERBB2 on Survival in Stage II/III Gastric Cancer

  2012cited by this paper
• Association of HER2/ErbB2 Expression and Gene Amplification with Pathologic Features and Prognosis in Esophageal Adenocarcinomas

  2012cited by this paper
• Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.

  2012cited by this paper
• Prognostic and Predictive Role of JWA and XRCC1 Expressions in Gastric Cancer

  2012cited by this paper
• Prognostic value of expression of Kit67, p53, TopoIIa and GSTP1 for curatively resected advanced gastric cancer patients receiving adjuvant paclitaxel plus capecitabine chemotherapy.

  2012cited by this paper
• Genetic variants in genes involved in mechanisms of chemoresistance to anticancer drugs.

  2012cited by this paper
• Prognostic Role of Host Cyclooxygenase and Cytokine Genotypes in a Caucasian Cohort of Patients with Gastric Adenocarcinoma

  2012cited by this paper
• Trastuzumab: a novel standard option for patients with HER-2-positive advanced gastric or gastro-oesophageal junction cancer

  2012cited by this paper
• The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer

  2012cited by this paper
• The expression and function of organic anion transporting polypeptides in normal tissues and in cancer.

  2012cited by this paper
• The utility of the Hopkins Verbal Learning Test (Chinese version) for screening dementia and mild cognitive impairment in a Chinese population

  2012cited by this paper
• MET Activation Mediates Resistance to Lapatinib Inhibition of HER2-Amplified Gastric Cancer Cells

  2012cited by this paper
• Rosiglitazone Reverses Mitomycin C Resistance in Human Gastric Cancer Cells

  2012cited by this paper
• The effect of TRAIL on the expression of multidrug resistant genes MDR1, LRP and GST-π in drug-resistant gastric cancer cell SGC7901/VCR.

  2012cited by this paper
• Alpha-tocopheryl succinate enhances doxorubicin-induced apoptosis in human gastric cancer cells via promotion of doxorubicin influx and suppression of doxorubicin efflux.

  2011cited by this paper
• Prognostic factors in patients with diffuse type gastric cancer (linitis plastica) after operative treatment

  2011cited by this paper
• Tegafur/gimeracil/oteracil (S-1) approved for the treatment of advanced gastric cancer in adults when given in combination with cisplatin: a review comparing it with other fluoropyrimidine-based therapies

  2011cited by this paper
• Comprehensive analysis of localization of 78 solute carrier genes throughout the subsections of the rat gastrointestinal tract.

  2011cited by this paper
• Expression of apoptosis-related proteins and its clinical implication in surgically resected gastric carcinoma

  2011cited by this paper
• Association between DNA-repair polymorphisms and survival in pancreatic cancer patients treated with combination chemotherapy.

  2011cited by this paper
• MDR1 gene C3435T polymorphism is associated with clinical outcomes in gastric cancer patients treated with postoperative adjuvant chemotherapy.

  2011cited by this paper
• Genetic Polymorphism of GSTP1: Prediction of Clinical Outcome to Oxaliplatin/5-FU-based Chemotherapy in Advanced Gastric Cancer

  2010cited by this paper
• miR‐181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines

  2010cited by this paper
• A phase I/II and pharmacogenomic study of pemetrexed and cisplatin in patients with unresectable, advanced gastric carcinoma

  2010cited by this paper
• Association of gastric cancer incidence with MDR1 gene polymorphism in an ethnic Iranian population.

  2010cited by this paper
• Phosphoinositide 3-kinase/Akt and nuclear factor κB pathways are involved in tumor necrosis factor-related apoptosis-inducing ligand resistance in human gastric cancer cells.

  2010cited by this paper
• Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 in gastric cancer.

  2010cited by this paper
• The molecular basis of the chemosensitivity of metastatic cutaneous melanoma to chemotherapy

  2010cited by this paper
• MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta.

  2010cited by this paper
• MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2.

  2010cited by this paper
• New insights into the mechanisms of gastric cancer multidrug resistance and future perspectives.

  2010cited by this paper
• Functional Interactions of Cu-ATPase ATP7B with Cisplatin and the Role of ATP7B in the Resistance of Cells to the Drug*

  2009cited by this paper
• Overview of the molecular bases of resistance to chemotherapy in liver and gastrointestinal tumours.

  2009cited by this paper
• microRNA-451 Regulates Macrophage Migration Inhibitory Factor Production and Proliferation of Gastrointestinal Cancer Cells

  2009cited by this paper
• Biomarker analysis in stage III–IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival

  2009cited by this paper
• Facing the challenge of managing linitis plastica--review of the literature.

  2009cited by this paper
• Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy

  2009cited by this paper
• Allelic Imbalance at p53 and Microsatellite Instability Are Predictive Markers for Resistance to Chemotherapy in Gastric Carcinoma

  2009cited by this paper
• Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells

  2009cited by this paper
• Targeting apoptosis as an approach for gastrointestinal cancer therapy.

  2009cited by this paper
• Hepatobiliary transporters in the pharmacology and toxicology of anticancer drugs.

  2009cited by this paper
• Importance and limitations of chemotherapy among the available treatments for gastrointestinal tumours.

  2009cited by this paper
• Gastric cancer: the correlation between the clinicopathological factors and patients' survival (I).

  2009cited by this paper

• Identification of potentially deleterious mutations in gastric cancer using patient-derived xenograft models

  2026cites this paper
• Discovery of 1-(Azetidin-3-ylmethyl)-1H-benzo[d]imidazole Derivatives as Efficient GSTP1 Inhibitors for Gastric Cancer Treatment via Warhead Removal Strategy.

  2026cites this paper
• MCM10, a novel YAP1/TEAD4 target, drives gastric cancer progression by bridging DNA replication to stemness acquisition.

  2026cites this paper
• Helicobacter pylori CagA protein confers aggressive phenotypes to gastric cancer cells through the HIF-1α-mediated metabolic reprogramming

  2025cites this paper
• Lenvatinib Plus Paclitaxel as Second‐Line Therapy for Advanced Gastric Cancer Patients: A Dose Escalation Exploratory Study

  2025cites this paper
• Magnetic hyperthermia-triggered multi-functional thermo-responsive lipid nanoparticles for enhanced paclitaxel release and cytotoxicity

  2025cites this paper
• Cutting-edge nanotechnology: unveiling the role of zinc oxide nanoparticles in combating deadly gastrointestinal tumors

  2025cites this paper
• Nanomaterials in gastric cancer: pioneering precision medicine for diagnosis, therapy, and prevention

  2025cites this paper
• Prp19/CDC5L promotes gastric cancer via activation of the MAPK pathway-mediated homologous recombination

  2025cites this paper
• Wnt Pathway-Targeted Therapy in Gastrointestinal Cancers: Integrating Benchside Insights with Bedside Applications

  2025cites this paper
• Maraviroc/cisplatin combination inhibits gastric cancer tumoroid growth and improves mice survival

  2025cites this paper
• PUF60 Promotes Chemoresistance Through Drug Efflux and Reducing Apoptosis in Gastric Cancer

  2025cites this paper
• MiRNAs: main players of cancer drug resistance target ABC transporters

  2025cites this paper
• MiR-668-3p in M2 macrophage-derived exosomes activates autophagy through the ETS1/EGFR axis and promotes cisplatin resistance in gastric cancer

  2025cites this paper
• MTA1 upregulation enhances stemness and chemoresistance of gastric cancer cells

  2025cites this paper
• Cancer associated fibroblasts-derived SULF1 promotes gastric cancer metastasis and CDDP resistance through the TGFBR3-mediated TGF-β signaling pathway

  2024cites this paper
• Studying the non-coding RNA expression and its role in drug resistance mechanisms of gastric cancer.

  2024cites this paper
• In Vivo Detection of Multidrug-Resistance Related Proteins in Locally Advanced Breast Cancer Using 99mTc-MIBI SPECT/ CT Imaging: Correlation with Clinical Outcomes

  2024cites this paper
• Long noncoding RNAs as potential targets for overcoming chemoresistance in upper gastrointestinal cancers.

  2024cites this paper
• Cellular and Molecular Mechanisms of Chemoresistance for Gastric Cancer

  2024cites this paper
• The reactive stroma response regulates the immune landscape in prostate cancer

  2024cites this paper
• Nanoparticle co-delivery of carboplatin and PF543 restores platinum sensitivity in ovarian cancer models through inhibiting platinum-induced pro-survival pathway activation

  2024cites this paper
• New insights into targeted therapy of glioblastoma using smart nanoparticles

  2024cites this paper
• Allspice (Pimenta dioica) essential oil mediates sphingosine kinase inhibition and subsequent induction of apoptosis in gastric cancer cells

  2024cites this paper
• CX3CL1 and its receptor CX3CR1 interact with RhoA signaling to induce paclitaxel resistance in gastric cancer

  2024cites this paper
• Integrated Analysis Construct a Tumor-Associated Macrophage Novel Signature with Promising Implications in Predicting the Prognosis and Immunotherapeutic Response of Gastric Cancer Patients

  2024cites this paper
• Molecular Classifications in Gastric Cancer: A Call for Interdisciplinary Collaboration

  2024cites this paper
• MSC-NPRA loop drives fatty acid oxidation to promote stemness and chemoresistance of gastric cancer.

  2023cites this paper
• Mucoadhesive Carrier-Mediated Oral Co-delivery of Bcl2 Inhibitors Improves Gastric Cancer Treatment.

  2023cites this paper
• Tribbles Genes in Gastric Cancer: A Tumor-Suppressive Role for TRIB2

  2023cites this paper
• CDK5 promotes apoptosis and attenuates chemoresistance in gastric cancer via E2F1 signaling

  2023cites this paper
• Liposomal nanocarriers containing siRNA as small molecule-based drugs to overcome cancer drug resistance.

  2023cites this paper
• Exploring the mechanism of ellagic acid against gastric cancer based on bioinformatics analysis and network pharmacology

  2023cites this paper
• DKK1 Promotes Epithelial–Mesenchymal Transition and Cisplatin Resistance in Gastric Cancer via Activation of the PI3K/AKT Pathway

  2023cites this paper
• Serum basic fibroblast growth factor and interleukin-1β predict the effect of first-line chemotherapy in patients with advanced gastric cancer

  2023cites this paper
• Participation of protein metabolism in cancer progression and its potential targeting for the management of cancer

  2023cites this paper
• Isoliensinine augments the therapeutic potential of paclitaxel in multidrug‐resistant colon cancer stem cells and induced mitochondria‐mediated cell death

  2023cites this paper
• Integrated single-cell RNA sequencing analysis reveals a mesenchymal stem cell-associated signature for estimating prognosis and drug sensitivity in gastric cancer

  2023cites this paper
• Genetically engineered neural stem cells expressing cytosine deaminase and interferon-beta enhanced T cell-mediated antitumor immunity against gastric cancer in a humanized mouse model.

  2023cites this paper
• MFAP2 enhances cisplatin resistance in gastric cancer cells by regulating autophagy

  2023cites this paper
• Reciprocal Regulation of Cancer-Associated Fibroblasts and Tumor Microenvironment in Gastrointestinal Cancer: Implications for Cancer Dormancy

  2023cites this paper
• Tissue Inhibitors of Metalloproteinases 1 Confers 5-Fluorouracil Resistance and Stemness of Gastric Cancer Cells via the Up-Regulation of Hypoxia-Inducible Factor-1α

  2023cites this paper
• RNA helicase DDX5-induced circPHF14 promotes gastric cancer cell progression

  2023cites this paper
• The roles and molecular mechanisms of long non-coding RNA WT1-AS in the maintenance and development of gastric cancer stem cells.

  2023cites this paper
• The critical role of circular RNAs in drug resistance in gastrointestinal cancers

  2023cites this paper
• Antitumoral Activity of Leptocarpha rivularis Flower Extracts against Gastric Cancer Cells

  2023cites this paper
• EZH2: An Accomplice of Gastric Cancer

  2023influential citation
• Recent progress in the development of nanomaterials targeting multiple cancer metabolic pathways: a review of mechanistic approaches for cancer treatment

  2023cites this paper
• Targeting mitochondria as a therapeutic anti-gastric cancer approach

  2022cites this paper
• The Interaction Between SMAD1 and YAP1 Is Correlated with Increased Resistance of Gastric Cancer Cells to Cisplatin

  2022cites this paper
• Upregulation of CRABP2 by TET1-mediated DNA hydroxymethylation attenuates mitochondrial apoptosis and promotes oxaliplatin resistance in gastric cancer

  2022cites this paper
• Thiostrepton confers protection against reactive oxygen species-related apoptosis by restraining FOXM1-triggerred development of gastric cancer.

  2022cites this paper
• Valrubicin decreases cell proliferation in gastric cancer through the apoptosis induction

  2022cites this paper
• PI3K/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells

  2022cites this paper
• Cooperative Treatment of Gastric Cancer Using B7-H7 siRNA and Docetaxel; How Could They Modify Their Effectiveness?

  2022cites this paper
• Neoadjuvant apatinib plus tegafur/gimeracil/oteracil potassium (S‑1)/oxaliplatin chemotherapy vs. chemotherapy alone in patients with locally advanced gastric carcinoma

  2022cites this paper
• Targeting ZFP64/GAL-1 axis promotes therapeutic effect of nab-paclitaxel and reverses immunosuppressive microenvironment in gastric cancer

  2022cites this paper
• Assessment of the Effect of Overexpression of Death-Associated Protein Kinases 3 Using PEGFPN1 on Gastric Adenocarcinoma Cell Line (MKN45)

  2022cites this paper
• Clinical significance and prospective molecular mechanism of NUF2 in gastric cancer exploration: A comprehensive study based on the GeneChip, GEO, Oncomine, and TCGA databases

  2022cites this paper
• Circ_0081143 Contributes to Gastric Cancer Malignant Development and Doxorubicin Resistance by Elevating the Expression of YES1 by Targeting mziR-129-2-3p

  2022cites this paper
• UBAP2L promotes gastric cancer metastasis by activating NF-κB through PI3K/AKT pathway

  2022cites this paper
• Ginsenoside Rg3 Alleviates Cisplatin Resistance of Gastric Cancer Cells Through Inhibiting SOX2 and the PI3K/Akt/mTOR Signaling Axis by Up-Regulating miR-429

  2022cites this paper
• A Network Pharmacology Perspective Investigation of the Pharmacological Mechanisms of the Herbal Drug FDY003 in Gastric Cancer

  2022cites this paper
• Genetic and molecular biology of gastric cancer among Iranian patients: an update

  2022cites this paper
• miR-4486 enhances cisplatin sensitivity of gastric cancer cells by restraining the JAK3/STAT3 signalling pathway

  2021cites this paper
• Circular RNA circVAPA promotes chemotherapy drug resistance in gastric cancer progression by regulating miR-125b-5p/STAT3 axis

  2021cites this paper
• MicroRNA-95-3p serves as a contributor to cisplatin resistance in human gastric cancer cells by targeting EMP1/PI3K/AKT signaling

  2021cites this paper
• Tryptophanol-Derived Oxazolopyrrolidone Lactams as Potential Anticancer Agents against Gastric Adenocarcinoma

  2021cites this paper
• Investigations into the effects and related upstream/downstream regulatory mechanisms of long non-coding RNA WT1-AS in the maintenance and development of gastric cancer stem cells in vitro and in vivo

  2021cites this paper
• MicroRNA-665 regulates the proliferation, apoptosis and adhesion of gastric cancer cells by binding to cadherin 3

  2021cites this paper
• Prognosis prediction model for a special entity of gastric cancer, linitis plastica.

  2021cites this paper
• Effect and mechanisms of LINC00152 knockdown on chemotherapy resistance in mitomycin-resistant gastric cancer NCI-N87/MMC cells

  2021cites this paper
• RP11-874J12.4, a novel lncRNA, confers chemoresistance in human gastric cancer cells by sponging miR-3972 and upregulating SSR2 expression.

  2021cites this paper
• Zinc oxide nanoparticles reduce the chemoresistance of gastric cancer by inhibiting autophagy

  2021cites this paper
• Curcumin–cisplatin chemotherapy: A novel strategy in promoting chemotherapy efficacy and reducing side effects

  2021cites this paper
• Evolutionary Mechanisms of Cancer Suggest Rational Therapeutic Approaches

  2021cites this paper
• Ultrasound and Transcriptomics Identify a Differential Impact of Cisplatin and Histone Deacetylation on Tumor Structure and Microenvironment in a Patient-Derived In Vivo Model of Gastric Cancer

  2021cites this paper
• Current Advances and Outlook in Gastric Cancer Chemoresistance: A Review.

  2021cites this paper
• A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer

  2021cites this paper
• Apoptosis Induction with Combined Use of Cisplatin and Fisetin in Cisplatin-Resistant Ovarian Cancer Cells (A2780)

  2021cites this paper
• MicroRNA-214 in Health and Disease

  2021cites this paper
• CircARVCF Contributes to Cisplatin Resistance in Gastric Cancer by Altering miR-1205 and FGFR1

  2021cites this paper
• Mechanisms of Action And Clinical Implications of MicroRNAs in the Drug Resistance of Gastric Cancer

  2021cites this paper
• LncRNA DLGAP1-AS2 overexpression associates with gastric tumorigenesis: a promising diagnostic and therapeutic target

  2021cites this paper
• The caspase-3/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer

  2020cites this paper
• Molecular Bases of Mechanisms Accounting for Drug Resistance in Gastric Adenocarcinoma

  2020cites this paper
• Silencing of miR490-3p by H. pylori activates DARPP-32 and induces resistance to gefitinib.

  2020cites this paper
• Drug resistance in cancer: mechanisms and tackling strategies

  2020cites this paper
• Expression of DCP1a in gastric cancer and its biological function and mechanism in chemotherapy resistance in gastric cancer cells.

  2020cites this paper
• Exosomal MiR‐500a‐3p promotes cisplatin resistance and stemness via negatively regulating FBXW7 in gastric cancer

  2020cites this paper
• Clinical outcomes of radical gastrectomy following trastuzumab-based chemotherapy for stage IV HER2-positive gastric or gastroesophageal junction cancer

  2020cites this paper
• miR-424-3p Contributes to the Malignant Progression and Chemoresistance of Gastric Cancer

  2020cites this paper
• Role of CC Chemokines Subfamily in the Platinum Drugs Resistance Promotion in Cancer

  2020cites this paper
• Retracted: Targeted Regulation of FoxO3a by miR-372 to Mediate Gastric Carcinoma Cell Apoptosis and DDP Drug Resistance

  2020cites this paper
• Interferon regulatory factor-1 suppresses DNA damage response and reverses chemotherapy resistance by downregulating the expression of RAD51 in gastric cancer.

  2020cites this paper
• Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer

  2020cites this paper
• miR-99a-5p as Possible Diagnostic and Prognostic Marker in Patients With Gastric Cancer.

  2020cites this paper
• lncRNA ROR Promotes Gastric Cancer Drug Resistance

  2020cites this paper
• Functional and transcriptomic characterization of cisplatin-resistant AGS and MKN-28 gastric cancer cell lines

  2020cites this paper
• Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons

  2020cites this paper